TAK

Takeda Pharmaceutical Company Limited

14.56 USD
-0.04 (-0.24%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Takeda Pharmaceutical Company Limited stock is down -0.31% since 30 days ago. The next earnings date is May 9, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 31.25% of the previous 16 March’s closed higher than February.

About Takeda Pharmaceutical Company Limited

Takeda Pharmaceutical Company Limited engages in the research, development, manufacturing, marketing, and out-licensing of pharmaceutical products. It offers pharmaceutical products in gastroenterology; oncology; neuroscience; and rare diseases. The company provides its products under the Entyvio, Gattex/Revestive, Alofisel, Natpara, Adynovate/Adynovi, Takhzyro, Elaprase, Vpriv, Gammagard Liquid/Kiovig.